India mandates doctor's prescription for purchase of cough syrups and syrups under Drugs Rules, 2026

Key Facts

• Date of Notification: 16 June 2026
• Regulation Notified: Drugs (Fifth Amendment) Rules, 2026
• Amendment Detail: Removal of the term “syrups” from Schedule K of the Drugs Rules, 1945
• Effect: Syrup-based formulations, including commonly used cough syrups such as Benadryl, Glycodin, Zedex, Tusq DX, Grilinctus, Cofsils, Himalaya Koflet, and Dabur Honitus, now require a doctor’s prescription
• Legal Authority: Sections 12 and 33 of the Drugs and Cosmetics Act, 1940 empower the amendment
• Drugs Exempt from Prescription: Lozenges, pills, and tablets used for cough treatment remain exempt under Schedule K and can be purchased over the counter
• Context: The regulation responds to contamination-linked child deaths in Madhya Pradesh and Rajasthan, highlighting safety concerns
• Regulatory Bodies involved: Ministry of Health and Family Welfare and Drugs Technical Advisory Board (DTAB)

Background & Context

The Drugs Rules, 1945, govern the manufacture, sale, and distribution of medicines in India, under the framework of the Drugs and Cosmetics Act, 1940. Schedule K of these rules lists certain medicines exempt from some regulatory provisions, allowing for over-the-counter sale under specified conditions. "Syrups" had been included among these exemptions, making many syrup-based formulations, including cough syrups, accessible without prescription.

However, incidents of contaminated cough syrups causing multiple child fatalities, notably in Madhya Pradesh and Rajasthan, raised significant public health concerns. Following public consultations beginning with a draft notification in December 2025 and thorough review including expert input from the Drugs Technical Advisory Board, the government finalized the amendment. The change removes "syrups" from Schedule K, thereby requiring these formulations to be sold only against a registered medical practitioner's prescription.

Why This Matters for Exams / Exam Relevance

• Amendments to the Drugs Rules, 1945, form an important part of studying India's drug regulatory framework in health governance.
• Understanding Schedule K and the categories of drugs exempt from prescription regulations is important for legal and medical regulatory examinations.
• The Ministry of Health and Family Welfare’s role, along with advisory bodies such as the Drugs Technical Advisory Board, are key institutions in Indian public health administration often covered in exams.
• The recent amendment is a direct government response to public health incidents, providing a contemporary example of policy-making and regulatory adjustments.
• Specific dates (16 June 2026) and legal provisions (Sections 12 and 33 of the Drugs and Cosmetics Act, 1940) are factual details frequently asked in multiple-choice questions (MCQs) and descriptive answers.

Points to Remember

• The Drugs (Fifth Amendment) Rules, 2026, came into effect immediately upon notification in the Official Gazette.
• The word "syrups" was specifically removed from item number seven under Schedule K, ending their over-the-counter status.
• Common cough syrups like Benadryl, Glycodin, Zedex, Tusq DX, Grilinctus, Cofsils, Himalaya Koflet, and Dabur Honitus require doctor's prescription post-amendment.
• Other formulations such as lozenges, pills, and tablets for cough remain exempt and are available OTC.
• The amendment was based on public safety concerns, mainly contamination-linked deaths among children reported in some Indian states.
• The Drugs Technical Advisory Board was consulted in the rule-making process.
• These regulatory changes apply uniformly throughout India under the Drugs Rules, 1945 and the Drugs and Cosmetics Act, 1940.